Navigation Links
Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Sankyo
Date:2/22/2011

SEATTLE, Feb. 22, 2011 /PRNewswire/ -- Omeros Corporation (Nasdaq: OMER) today announced that its exclusive license to phosphodiesterase 7 (PDE7) inhibitors from Daiichi Sankyo Co., Ltd. has been amended to include addiction and compulsive disorders in the field of use. Omeros' PDE7 program was founded on the Company's discovery of a previously unknown link between PDE7 and any movement disorder, such as Parkinson's disease.  Omeros believes that it also is the first to link PDE7 to any addiction or compulsive behavior, and is now advancing PDE7 inhibitors for the treatment of these as well as movement disorders. Omeros is collaborating on this program with both the National Institute on Drug Abuse (NIDA) and The Michael J. Fox Foundation.

"We are pleased to announce our agreement with Daiichi Sankyo and the additional therapeutic focus of our PDE7 program," stated Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "From the advanced Daiichi compounds we have already selected a clinical candidate, and we expect that addiction will provide us with a faster and less expensive development pathway for our PDE7 program. We are collaborating with NIDA on additional studies that will evaluate our compounds in addiction, and we look forward to working with NIDA to advance this program through the clinic."

PDE7 appears to modulate the dopaminergic system, which plays a significant role in regulating both movement and addiction. Omeros believes that PDE7 inhibitors could be effective therapeutics for the treatment of movement disorders as well as addiction and compulsive disorders. Omeros has shown in animal models of cocaine addiction that PDE7 inhibitors reduce cocaine self-administration, inhibit relapse induced by cues and stress, and facilitate drug abstinence in previously addicted animals. Importantly, no effect on normal feeding was observed
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Announces Publication of Data From Antifibrinolytic Program
2. Omeros Licenses Novel Antifibrinolytic Agents
3. Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy
4. Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update
5. Omeros to Present at the BioCentury NewsMakers Conference
6. Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery
7. Omeros Successfully Unlocks Orphan GPCRs
8. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
9. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
10. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
11. Daniel K. Spiegelman Elected to Board of Directors of Omeros
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  RESMED INC. (NYSE: ... quarter and fiscal year ended June 30, 2014 results on ... market close. A press release with ResMed,s results will be ... will host a webcast to discuss operating results and future ... at 1:30 p.m. US Pacific Time and the live webcast ...
(Date:7/10/2014)... , July 10, 2014  Decision Resources Group ... infectious disease (ID) specialists are willing to prescribe ... (oritavancin) for use as OPAT, approximately two-thirds of ... agents to their hospital inpatients. However, our findings ... patients are initiated on OPAT following hospital discharge, ...
(Date:1/15/2014)... ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" research ... http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging of ... orthopedic instrument industry has seen rapid development ... 3.28 billion yuan in 2006 to 9.85 billion yuan ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... Six years ago, before smartphones were a veritable cornerstone ... Michigan joined an initiative to begin using similar handheld ... prescribe medications for their patients.  Today, ... (SEMI) reports that more than 7,500 physicians in the ...
... 28, 2012 Bionovo, Inc. (OTCQB: BNVI), a pharmaceutical company ... effective treatments for women,s health and cancer, announced today ... recommended that the Phase 3 trial of Menerba (MF101) ... its clinical safety and tolerability data. Menerba is Bionovo,s ...
Cached Medicine Technology:Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 2Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 3Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 4Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 5Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 6Entering its Prime: Southeast Michigan ePrescribing Initiative, One of the Nation's Longest Running ePrescribing Programs, Increases Enrollment by 33 Percent; Kicks off Seventh Year 7Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 2Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 3Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 4
(Date:7/10/2014)... health concerns in the United States, with 32 percent ... 2012. As health problems such as childhood obesity grow, ... the problem. , A new study, led by Jenine ... at Washington University in St. Louis, examined the use ... conversations about the issue of overweight kids. , The ...
(Date:7/10/2014)... Human Services (HHS) has announced a three-year grant to ... totaling $4.7 million to support a new national model ... , Titled "Evidence-Conformant Oncology Care," the project will ... care for adult cancer patients with late-stage disease, significant ... , "We believe that the best cancer ...
(Date:7/10/2014)... Up to 70% of Parkinson,s disease (PD) ... quality of life. Some patients have disturbed sleep/wake ... asleep, while other patients may be subject to ... extreme, PD patients may exhibit REM-sleep behavior disorder ... re-enactment, even before motor symptoms appear. A review ...
(Date:7/10/2014)... at the University of Huddersfield could help to improve ... food products such as butter, mayonnaise, yoghurt and ... an international profile for her work. , Katerina gained ... the University and now she has embarked on research ... Vassilis Kontogiorgos, she is investigating the potential of carbohydrates ...
(Date:7/10/2014)... identifying the clinical indicators most strongly associated with concussion ... developing evidence-based guidelines for concussion diagnosis, prognosis, and treatment, ... Neurosurgery , official journal of the ... by Lippincott Williams & Wilkins , a part ... Based on analysis of the best available research data, ...
Breaking Medicine News(10 mins):Health News:Study looks at how Twitter can be used to address specific health issues 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3Health News:Sleep disturbances, common in Parkinson's disease, can be early indicator of disease onset 2Health News:World interest in research work on the benefits of the Okra plant 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3
... typically ones headed by a medical doctor rather than a manager. ... makes a good hospital. The research, to be published in ... first of its kind. Its conclusions run counter to a ... -- not those with a medical degree -- at the helm ...
... By pairing an award-winning remote-detection version of NMR/MRI ... designed for microfluidic chips, researchers with the U.S. ... (Berkeley Lab) have opened the door to a ... that would be impractical if not impossible with ...
... , WEDNESDAY, July 6 (HealthDay News) -- Brief, voluntary ... reduce their use of the drug, according to a new ... to these discussions about marijuana was more effective than merely ... drug. Marijuana is a common drug choice for teens ...
... form of brain tumor in people. Research published in ... Design offers a novel way to determine what ... to form. Understanding the problems at the molecular level ... in glioblastoma and ultimately lead to treatments or even ...
... , WEDNESDAY, July 6 (HealthDay News) -- Being satisfied with ... the finding of a new study that included almost 8,000 ... their satisfaction in seven areas of their lives: romantic relationships, ... self. Over a follow-up period of about six years, ...
... ablative radiotherapy and improvements in surgical care in early-stage ... elderly Dutch patients, according to a population-based study presented ... Amsterdam, hosted by the International Association for the Study ... Dutch non-small cell lung cancer (NSCLC) patients increased by ...
Cached Medicine News:Health News:The best hospitals are run by physicians 2Health News:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 2Health News:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 3Health News:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 4Health News:Talking to Teens May Help Them Cut Back on Pot Smoking 2Health News:What causes brain cancer? 2Health News:Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009 2
... interoperative placement to stent the ... and continent urinary diversions. Supplied ... for one-time use. CAUTION: Periodic ... not remain indwelling more than ...
... a device that provides effective cutting and simultaneous ... to provide the urologist with the same touch ... the approximate speed and the same ease of ... but with a 45% greater zone of ...
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: